FDx Advisors’s Phibro Animal Health PAHC Stock Holding History

FDx Advisors’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7,380	Closed	-$293K	–	1030
2018 Q1	$293K	Sell	7,380 -392	-5%	-$14.5K	0.01%	968
2017 Q4	$260K	Sell	7,772 -136	-2%	-$4.83K	0.01%	1096
2017 Q3	$293K	Hold	7,908	–	–	0.01%	1048
2017 Q2	$293K	Sell	7,908 -1,133	-13%	-$37K	0.01%	992
2017 Q1	$254K	Sell	9,041 -1,053	-10%	-$29.7K	0.01%	1030
2016 Q4	$296K	Buy	10,094 +918	+10%	+$25.1K	0.01%	957
2016 Q3	$249K	Buy	+9,176	New	+$208K	0.01%	826

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CVA

Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return

FIM

Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CRCP

Copper Rock Capital Partners Boston, Massachusetts $296M AUM 28.61% 1-Year Est. Return

FDx Advisors's PAHC Position: Q2 2018 in Review

FDx Advisors sold out of Phibro Animal Health (PAHC) in Q2 2018, closing a stake of 7,380 shares — an estimated $293K sold.

FDx Advisors first reported a position in PAHC in Q3 2016 and held it in 7 quarters. The position peaked at $296K in Q4 2016. 174 funds tracked by Wall St. Rank hold PAHC as of Q2 2018.

FDx Advisors reported no remaining Phibro Animal Health position as of Q2 2018 after selling out during the quarter.
FDx Advisors sold 7,380 Phibro Animal Health shares in Q2 2018, an estimated $293K.
FDx Advisors first reported a position in Phibro Animal Health in Q3 2016 and held it in 7 quarters.
FDx Advisors's Phibro Animal Health position peaked at $296K in Q4 2016.
174 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2018.

Based on FDx Advisors's 13F filing for Q2 2018, filed 8 Aug 2018.